Log in to search using one of your social media accounts:

 

'Safer and more accurate' Down's test for Wales
Non-invasive prenatal testing will become standard following introduction in England Related items fromOnMedica Leading the way with NHS Screening Programmes Blood test identifies high-risk lupus pregnancies New NHS screening for Down's expected soon CMO sets out plans to achieve ‘genomic dream’ The next generation of prenatal testing: let ’s proceed with caution (Source: OnMedica Latest News)
Source: OnMedica Latest News - August 22, 2017 Category: UK Health Source Type: news

Lupus Survival Plateaus after Earlier Improvements (CME/CE)
(MedPage Today) -- Lag in middle/low-income countries, especially among children (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - August 20, 2017 Category: Rheumatology Source Type: news

Finding cures for incurable diseases
By Sandra Raymond, president and CEO, The Lupus Foundation of America (Source: The Catalyst)
Source: The Catalyst - July 25, 2017 Category: Pharmaceuticals Authors: Guest Contributor Tags: Medicines in Development Lupus New Era of Medicine Source Type: news

Single Mom With 2 Failing Kidneys Saved By Stranger
WINCHESTER (CBS) – A single mother with two failing kidneys was saved by the kindness of a complete stranger. “I work as a web developer. She’s a web designer,” Kara Yimoyines said. “She’s from the Midwest. I’m from the Midwest,” said Nicole Baltzer. “We both like sports.” This months-old friendship feels in so many ways meant to be. Once-strangers in the same town, now connected for life. “I certainly never set out to be a living donor as part of my life plan,” Nicole said. Nicole Baltzer and Kara Yimoyines (WBZ-TV) But that plan took a new direction,...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 25, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Syndicated Local Juli McDonald kidney donation Tufts Medical Center Winchester Source Type: news

Self-Injectable Benlysta Approved in Lupus
(MedPage Today) -- Subcutaneous belimumab OK'd based on placebo-controlled trial (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - July 21, 2017 Category: American Health Source Type: news

GSK Receives FDA Approval for a New Self-Injectable Formulation of Benlysta (belimumab) for Systemic Lupus Erythematosus
London, UK 21 July 2017 -- GSK announced today that the US Food and Drug Administration (FDA) has approved a new subcutaneous formulation of Benlysta (belimumab) for the treatment of adult patients with active, autoantibody ‑positive SLE who are... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 21, 2017 Category: Drugs & Pharmacology Source Type: news

Large multi-ethnic study identifies many new genetic markers for lupus
(Wake Forest Baptist Medical Center) Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 17, 2017 Category: International Medicine & Public Health Source Type: news

Researcher identifies possible cause for lupus
A rheumatologist at the Feinstein Institute for Medical Research has possibly identified a protein as a cause for the adverse immune system response in lupus. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 14, 2017 Category: Consumer Health News Source Type: news

Prevalence of Pulmonary Embolism Among SLE Discharges Prevalence of Pulmonary Embolism Among SLE Discharges
This study takes a closer look.Journal of Clinical Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 14, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Feinstein Institute identifies potential cause for lupus
(Northwell Health) Research profiles how a particular protein could cause immune system to attack healthy cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 14, 2017 Category: International Medicine & Public Health Source Type: news

What Are Safe Exercises with Lupus?
Title: What Are Safe Exercises with Lupus?Category: Doctor's& Expert's views on SymptomsCreated: 7/12/2017 12:00:00 AMLast Editorial Review: 7/12/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - July 12, 2017 Category: Rheumatology Source Type: news

Prompt Evaluation of Lung Bleeds Needed in Lupus
(MedPage Today) -- Low hemoglobin, low C4 and hypoxia are features of poor outcome (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - July 9, 2017 Category: Respiratory Medicine Source Type: news

Pregnancy Found Safe in Lupus
(MedPage Today) -- PROMISSE gives reassurance (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - July 8, 2017 Category: OBGYN Source Type: news

Lupus Damage Goes Up When Care Quality Goes Down
(MedPage Today) -- Communication, coordination flubs have consequences in outcomes (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 6, 2017 Category: Primary Care Source Type: news

Neovacs and Centurion sign licence agreement for lupus treatment IFNalpha Kinoid in Turkey
French biotechnology company Neovacs has signed an exclusive licence agreement with Centurion Pharma for IFNalpha Kinoid to treat patients with lupus in Turkey. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - July 5, 2017 Category: Pharmaceuticals Source Type: news

Is Lupus Hereditary?
Title: Is Lupus Hereditary?Category: Doctor's& Expert's views on SymptomsCreated: 6/30/2017 12:00:00 AMLast Editorial Review: 6/30/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - June 30, 2017 Category: Rheumatology Source Type: news

Papers of note in Nature 546 (7659)
This week’s articles describe engineered exosomes for treating pancreatic cancer, the role of the endoplasmic reticulum in cancer cell apoptosis, the priming of brown fat for cold-induced thermogenesis, synapse loss in a mouse model of lupus, and communication between cells of different lineages during liver development. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - June 27, 2017 Category: Science Authors: VanHook, A. M. Tags: STKE Editors ' Choice Source Type: news

Lupus symptoms: Scientists discover TRIGGER for life-threatening autoimmune disease
LUPUS is an autoimmune condition that can become dangerous, but it remains poorly understood and its cause unknown. (Source: Daily Express - Health)
Source: Daily Express - Health - June 23, 2017 Category: Consumer Health News Source Type: news

Is Polyarteritis Nodosa Different from Lupus?
Title: Is Polyarteritis Nodosa Different from Lupus?Category: Doctor's& Expert's views on SymptomsCreated: 6/21/2017 12:00:00 AMLast Editorial Review: 6/21/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - June 21, 2017 Category: Rheumatology Source Type: news

Shortage of Pediatric Rheumatologists Tied to Delays in Lupus Care Shortage of Pediatric Rheumatologists Tied to Delays in Lupus Care
Some young children with lupus wait a year or more to be treated by a pediatric rheumatologist, researchers in New York City have found.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - June 20, 2017 Category: Orthopaedics Tags: Pediatrics News Source Type: news

GSK ’s Benlysta shows positive outcome in Phase II continuation trial for SLE
GlaxoSmithKline (GSK) reported positive data from the Phase II ten-year continuation clinical trial of Benlysta (belimumab) in combination with standard-of-care for patients suffering from systemic lupus erythematosus (SLE). (Source: Drug Development Technology)
Source: Drug Development Technology - June 19, 2017 Category: Pharmaceuticals Source Type: news

New blood test detects stroke and heart attack risk in lupus patients with no CVD symptoms
(European League Against Rheumatism) The results of a study presented today at the Annual European Congress of Rheumatology 2017 press conference have shown that a specific biomarker detected in the blood of lupus patients with no symptoms of cardiovascular disease (CVD), thought to be at low risk of CVD based on traditional risk factors, is associated with the presence of atherosclerosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 15, 2017 Category: International Medicine & Public Health Source Type: news

Prevalence of Antiphospholipid Syndrome Up for Roma SLE
Roma systemic lupus erythematosus patients also have significantly higher prevalence of abortions (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 14, 2017 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Rheumatology, Journal, Source Type: news

A surprising new link between inflammation and mental illness
(Boston Children's Hospital) Up to 75 percent of patients with systemic lupus erythematosus -- an incurable autoimmune disease commonly known as lupus -- experience neuropsychiatric symptoms. But so far, our understanding of the mechanisms underlying lupus' effects on the brain has remained murky. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2017 Category: International Medicine & Public Health Source Type: news

When It's Not A Sunburn But A Sun Allergy
As it gets warmer and people start spending more time outside, I have more and more patients coming into my office and complaining of a “sun allergy.” A sun allergy is really a layman’s term, which refers to a number of conditions when a rash occurs on skin that has been exposed to the sun. These are also referred to as photosensitive disorders or photodermatoses, and can be broadly categorized into the following medical terms: idiopathic photodermatoses, exogenous photodermatoses, photoexacerbated dermatoses, genetic photodermatoses, and metabolic photodermatoses. Sounds complicated, right?  A...
Source: Healthy Living - The Huffington Post - June 8, 2017 Category: Consumer Health News Source Type: news

Hemolysis Risk Low With Lupus Drug (CME/CE)
(MedPage Today) -- Hydroxychloroquine not tied to hemolytic anemia in certain patients (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 6, 2017 Category: Primary Care Source Type: news

Why Black Women Should Care About Congress Taking Away Health Care
By Erica Hilton In 2013, I woke up one day and was unable to open my left eye. Daylight tortured my eye. Bright lights were impossible. This was a painful interruption in the excitement and promise of my life. I had recently earned my master’s degree and started my “dream job” as an online activism manager. Here I was in the middle of this new journey, and I couldn’t keep one eye open. I made an emergency appointment with an ophthalmologist who then sent me to see a specialist. The inflammation in my eye remained for weeks. Eventually it cleared up only to reoccur again a few weeks later. Since 2013...
Source: Healthy Living - The Huffington Post - June 5, 2017 Category: Consumer Health News Source Type: news

Omega-3 fatty acid stops lupus trigger, but how?
(Michigan State University) Michigan State University scientists have received a $2.3 million, five-year National Institutes of Health grant to help uncover why an omega-3 fatty acid, known as DHA, is so effective in stopping a known trigger of lupus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 1, 2017 Category: International Medicine & Public Health Source Type: news

Poverty Affects Severity of Organ Damage Due to Lupus
And, pregnancy complications higher among non - white patients with lupus (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 23, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Gynecology, Internal Medicine, Nephrology, Neurology, Nursing, Pathology, Pulmonology, Rheumatology, Journal, Source Type: news

Poverty Could Make Lupus Even Worse
Title: Poverty Could Make Lupus Even WorseCategory: Health NewsCreated: 5/19/2017 12:00:00 AMLast Editorial Review: 5/22/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - May 22, 2017 Category: Rheumatology Source Type: news

Joint pain could be a symptom of THIS potentially life-threatening condition
LUPUS is a complex disease which affects individuals in many different ways and with differing severity. Joint pain is one of the main symptoms of the condition. (Source: Daily Express - Health)
Source: Daily Express - Health - May 21, 2017 Category: Consumer Health News Source Type: news

Poverty Could Make Lupus Even Worse
Second study saw pregnancy complications higher among non-whites Source: HealthDay Related MedlinePlus Pages: Health Disparities, Health Problems in Pregnancy, Lupus (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 19, 2017 Category: Consumer Health News Source Type: news

Poverty Could Make Lupus Even Worse
FRIDAY, May 19, 2017 -- Poverty and race are tied to the health of lupus patients in the United States, according to two new studies. One study of 783 patients linked poverty to an increased risk of organ damage from the autoimmune disease. It was... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 19, 2017 Category: General Medicine Source Type: news

Living with lupus: what it's like having an invisible illness
Lisa Walters is a 28-year-old living with lupus, or what she refers to as an invisible illness. (Source: CBC | Health)
Source: CBC | Health - May 19, 2017 Category: Consumer Health News Tags: News/Canada/NL Source Type: news

Aurinia begins voclosporin dosing in Phase III trial for LN
Canadian-based biopharmaceutical firm Aurinia Pharmaceuticals has begun dosing patients in the Phase III AURORA clinical trial of voclosporin to treat lupus nephritis (LN). (Source: Drug Development Technology)
Source: Drug Development Technology - May 18, 2017 Category: Pharmaceuticals Source Type: news

Systemic Lupus Erythematosus: Osmosis Study Video Systemic Lupus Erythematosus: Osmosis Study Video
This video covers the known pathophysiology behind systemic lupus erythematosus, as well as the diagnostic criteria, signs and symptoms, and treatment. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 16, 2017 Category: Consumer Health News Tags: Med Students Commentary Source Type: news

Erratum for the Research Article: "Reactive oxygen species induce virus-independent MAVS oligomerization in systemic lupus erythematosus" by I. A. Buskiewicz, T. Montgomery, E. C. Yasewicz, S. A. Huber, M. P. Murphy, R. C. Hartley, R. Kelly, M. K. Crow, A. Perl, R. C. Budd, A. Koenig
(Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - May 16, 2017 Category: Science Tags: STKE Errata Source Type: news

New report reveals 1 in 4 children in UK lives in poverty
Poverty is ‘making children sick,’ say paediatricians Related items fromOnMedica NHS bears brunt of cost of poverty Studies reveal socioeconomic and race disparities in lupus Preschool tooth extractions rise by a quarter Child type 2 diabetes is a ‘wake-up call’ to the nation Eight-year-olds to get 'happiness lessons' (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 12, 2017 Category: UK Health Source Type: news

Researchers identify trigger for autoimmune disease
Researchers at National Jewish Health have identified age-associated B cells are a trigger for autoimmune diseases like lupus and Crohn's disease. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 11, 2017 Category: Consumer Health News Source Type: news

Boehringer begins enrolment in Phase II trial of BI 655064 to treat lupus nephritis
Pharmaceutical company Boehringer Ingelheim has begun patient enrolment in the Phase II clinical trial of BI 655064 for the treatment of lupus nephritis (LN). (Source: Drug Development Technology)
Source: Drug Development Technology - May 10, 2017 Category: Pharmaceuticals Source Type: news

Trigger for autoimmune disease identified
Researchers have identified a trigger for autoimmune diseases such as lupus, Crohn's disease and multiple sclerosis. The findings help explain why women suffer autoimmune disease more frequently than men, and suggest a therapeutic target to prevent autoimmune disease in humans. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 10, 2017 Category: Science Source Type: news

Phase II Trial now enrolling patients with Lupus Nephritis
(Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - May 10, 2017 Category: Research Source Type: news

Trigger for autoimmune disease identified
(National Jewish Health) Researchers at National Jewish Health have identified a trigger for autoimmune diseases such as lupus, Crohn's disease and multiple sclerosis. The findings help explain why women suffer autoimmune disease more frequently than men, and suggest a therapeutic target to prevent autoimmune disease in humans. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 10, 2017 Category: International Medicine & Public Health Source Type: news

Enteric-coated Mycophenolate Sodium May Trump Azathioprine for SLE Enteric-coated Mycophenolate Sodium May Trump Azathioprine for SLE
Enteric-coated mycophenolate sodium (EC-MPS) may treat systemic lupus erythematosus (SLE) more effectively than azathioprine (AZA) and prevent further relapses, researchers in Spain suggest.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 9, 2017 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news

Studies reveal socioeconomic and race disparities in lupus
Poverty linked with medical complications over time Related items fromOnMedica Arthritis may be a major driver of poverty NHS bears brunt of cost of poverty Rich and poor lifespan gap widens Blood test identifies high-risk lupus pregnancies (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 9, 2017 Category: UK Health Source Type: news

Studies show socioeconomic and racial disparities in lupus
Researchers have identified a link between socioeconomic and racial disparities in the severity and treatment of lupus. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 8, 2017 Category: Consumer Health News Source Type: news

Better Lupus Remission with Mycophenolate (CME/CE)
(MedPage Today) -- Complete SLE remission sooner, more frequent than with azathioprine (Source: MedPage Today State Required CME)
Source: MedPage Today State Required CME - May 5, 2017 Category: Consumer Health News Source Type: news

Renal Data Reassuring in Lupus Pregnancy (CME/CE)
(MedPage Today) -- De novo nephritis numbers were miniscule in prospective study (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - May 4, 2017 Category: OBGYN Source Type: news

GlaxoSmithKline announces $139 million investment in Rockville
British drug giant GlaxoSmithKline PLC (NYSE: GSK) is investing $139 million to expand its Rockville manufacturing site, saying it needs extra capacity there to meet anticipated demand for its lupus drug. Already, the Rockville location manufactures a drug substance in bulk for Benlysta as an intravenous formulation. That substance is also used to make GSK's asthma drug Nucala and its drug for inhaled anthrax called raxibacumab. But now, GSK is hoping to boost that bulk production by about 50 perce nt. The… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 1, 2017 Category: Pharmaceuticals Authors: Tina Reed Source Type: news

GlaxoSmithKline making $139M investment in Rockville plant
British drug giant GlaxoSmithKline PLC (NYSE: GSK) is investing $139 million to expand its Rockville manufacturing site, saying it needs extra capacity there to meet anticipated demand for its lupus drug. The expansion would allow the company to boost bulk production of a substance used in several of its drugs, including Benlysta, by about 50 percent. The expansion comes as the pharmaceutical giant is awaiting Food and Drug Administration approval to sell a new self-injectable form of Benlysta.… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - May 1, 2017 Category: Health Management Authors: Tina Reed Source Type: news